Relafen 750, pharmacologically known as naproxen, showcases a fascinating case study within the molecular pharmacy area. Its mechanism of action copyrights on inhibiting cyclooxygenase catalysts , specifically COX-1 and COX-2, thereby lessening the generation of prostaglandins, which are essential mediators of discomfort and heat. This targeted inh